Cervical intraepithelial neoplasia progression and regression among women living with <scp>HIV</scp> in Zambia
Cervical screening and precancer treatment are key to reducing cervical disease progression among WLWH and ultimately achieving cervical cancer elimination, but efforts to improve treatment effectiveness among WLWH must be balanced with the risk of overtreatment.
Authors
- Partha Basu (ORCID: https://orcid.org/0000-0003-0124-4050)
- Mulindi Mwanahamuntu (ORCID: https://orcid.org/0000-0001-6378-0276)
- Eliane Rohner (ORCID: https://orcid.org/0000-0002-0554-2875)
- John Andoh (ORCID: https://orcid.org/0000-0002-2770-0061)
- Misinzo Moono
- Albert Manasyan (ORCID: https://orcid.org/0000-0001-6275-245X)
- Katayoun Taghavi (ORCID: https://orcid.org/0000-0003-0812-0069)
- Nicola Low (ORCID: https://orcid.org/0000-0003-4817-8986)
- Thamsanqa Madliwa
Institutions
- University of Bern (CH)
- Centre for Infectious Disease Research in Zambia (ZM)
- University Teaching Hospital (ZM)
- University of Alabama at Birmingham (US)
- Lancet Laboratories (ZA)
- Institute of Social and Preventive Medicine (CH)
- Centre international de recherche sur le cancer (FR)
Publication Details
- Journal
- HIV Medicine
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1111/hiv.70134
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- National Science Foundation
- World Health Organization
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Swiss Cancer Research Foundation
- National Institutes of Health
- National Institute of Mental Health
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- Fogarty International Center
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Child Health and Human Development
- Eunice Kennedy Shriver National Institute of Child Health and Human Development